Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

November 30, 2007

Study Completion Date

October 31, 2009

Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG

bendamustine hydrochloride

DRUG

mitoxantrone hydrochloride

Trial Locations (12)

15526

Humaine - Clinic, Bad Saarow

26121

Internistische Gemeinschaftspraxis - Oldenburg, Oldenburg

41460

Internistische Praxis - Neuss, Neuss

47798

Haematologische / Onkologische Schwerpunktpraxis, Krefeld

59065

St. Marien Hospital, Hamm

96317

Internistische Onkologische Praxis - Kronach, Kronach

D-10117

Schwerpunktpraxis fuer Haematologie und Internistische Onkologie, Berlin

D-50677

Praxis Fuer Haematologie Internistische Onkologie, Cologne

06110

Internistische Gemeinschaftspraxis - Halle, Halle

D-56068

Praxis fuer Haematologie und Onkologie, Koblenz

D-92637

Haematologische Praxis, Weiden

D-65191

Deutsche Klinik fuer Diagnostik, Wiesbaden

All Listed Sponsors
lead

German CLL Study Group

OTHER

NCT00274963 - Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter